КАТЕТЕРНАЯ АБЛЯЦИЯ ПРИ ФИБРИЛЛЯЦИИ ПРЕДСЕРДИЙ И СОПУТСТВУЮЩЕЙ СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТИ

PUMTS. 2019; 34(2): 66-73

https://doi.org/10.31071/promedosvity2019.02.066

Фибрилляция предсердий и сердечная недостаточность — распространенные патологии в структуре сердечно-сосудистых заболеваний; часто наблюдается их сочетание, течение одной осложняет течение другой. Катетерная абляция при фибрилляции предсердий и сопутствующей хронической сердечной недостаточности за последние годы получила широкое применение в случае симптомного течения аритмии и неэффективности медикаментозного лечения. Проведен анализ литературы по эффективности и безопасности катетерной абляции у этой группы пациентов, особенно у такой противоречивой, как пациенты с сердечной недостаточностью с сохраненной фракцией выброса левого желудочка.

REFERENCES
  1. January, C. T., Wann, L. S., & Alpert, J. S. et al. (2014). 2014 AHA/ACC/ HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology / American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Journal of the American College of Cardiology, 4 (21), 2305–2307. https://doi.org/10.1161/CIR.0000000000000041
  2. Kirchhof, P., Benussi, S., & Kotecha, D. et al. (2017). 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Revista española de cardiología (English ed.), 70, 2–8. https://doi.org/10.1016/j.rec.2016.11.033
  3. Calkins, H., Hindricks, G., & Cappato, R. et al. (2017). 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary. Journal of arrhythmia, 33 (5), 369–409. https://doi.org/10.1016/j.joa.2017.08.001
  4. Wyse, D. G., Waldo, A. L., & DiMarcoet, J. P. al. (2002). A comparison of rate control and rhythm control in patients with atrial fibrillation. The New England journal of medicine, 347 (23), 1825–1833. https://doi.org/10.1056/NEJMoa021328
  5. Hunter, R. J., Berriman, T. J., & Diab, I. et al. (2014). A randomized controlled trial of catheter ablation versus medical treatment of atrial fibrillation in heart failure (the CAMTAF trial). Circulation. Arrhythmia and electrophysiology, 7, 31–38. https://doi.org/10.1161/CIRCEP.113.000806
  6. Biase, L. Di, Mohanty, P., & Mohanty, S. et al. (2016). Ablation versus amiodarone for treatment of persistent atrial fibrillation in patients with congestive heart failure and an implanted device: results from the AATAC Multicenter Randomized Trial. Circulation. Circulation, 133, 1637–1644. https://doi.org/10.1161/CIRCULATIONAHA.115.019406
  7. Zhang, Y., Chen, A., & Chen, L. et al. (2016). Association Between Baseline Natriuretic Peptides and Atrial Fibrillation Recurrence After Catheter Ablation. International heart journal, 57, 183–189. https://doi.org/10.1536/ihj.15-355
  8. Barra, S., Baran, J., & Narayanan, K. et al. (2018). Association of catheter ablation for atrial fibrillation with mortality and stroke: A systematic review and meta-analysis. International journal of cardiology, 266, 136–142. https://doi.org/10.1016/j.ijcard.2018.03.068
  9. Lobo, T. J., Pachon, C. T., & Pachon, J. C. et al. (2015). Atrial fibrillation ablation in systolic dysfunction: clinical and echocardiographic outcomes. Arquivos brasileiros de cardiologia, 104 (1), 45–52. https://doi.org/10.5935/abc.20140167
  10. Roy, D., Talajic, M., & Nattel, S. et al. (2008). Atrial Fibrillation and Congestive Heart Failure Investigators. Rhythm control versus rate control for atrial fibrillation and heart failure. The New England journal of medicine, 358 (25), 2667–2677.
  11. Santhanakrishnan, R., Wang, N., & Larson, M. G. et al. (2016). Atrial fibrillation begets heart failure and vice versa: temporal associations and differences in preserved versus reduced ejection fraction. Circulation, 133 (5), 484–492. https://doi.org/10.1161/CIRCULATIONAHA.115.018614
  12. Rattanawong, P., Upala, S., & Riangwiwat, T. et al. (2018). Atrial fibrillation is associated with sudden cardiac death: a systematic review and meta-analysis. Journal of interventional cardiac electrophysiology: an international journal of arrhythmias and pacing, 51 (2), 91–104. https://doi.org/10.1007/s10840-017-0308-9
  13. Baher, A., & Marrouche, N. (2018). Treatment of Atrial Fibrillation in Patients with Co-existing Heart Failure and Reduced Ejection Fraction: Time to Revisit the Management Guidelines? Arrhythmia & Electrophysiology Review, 7, 91–94. https://doi.org/10.15420/aer.2018.17.2
  14. AlTurki, A., Proietti, R. R, & Dawas, A. et al. (2019). Catheter ablation for atrial fibrillation in heart failure with reduced ejection fraction: a systematic review and meta-analysis of randomized controlled trials. BMC Cardiovascular Disorders. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6332840/. https://doi.org/10.1186/s12872-019-0998-2
  15. Marrouche, N. F., Brachmann, J., & Andresen, D. et al. (2018). Catheter Ablation for Atrial Fibrillation with Heart Failure. The New England journal of medicine, 378 (5), 417–427. https://doi.org/10.1056/NEJMoa1707855
  16. Ma, Y., Bai, F., & Qin, F. et al. (2018). Catheter ablation for treatment of patients with atrial fibrillation and heart failure: a meta-analysis of randomized controlled trials. BMC cardiovascular disorders. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6090632/. https://doi.org/10.1186/s12872-018-0904-3
  17. Costa Paiva, T., Fischer, T. H., Brachmann, J., & Busch, S. (2019). Catheter ablation of atrial fibrillation — a key role in heart failure therapy? Clinical cardiology, 42 (3), 400–405. https://doi.org/10.1002/clc.23150
  18. Ganesan, A. N., Nandal, S., & Lüker, J. et al. (2015). Catheter ablation of atrial fibrillation in patients with concomitant left ventricular impairment: a systematic review of efficacy and effect on ejection fraction. Heart, lung & circulation, 24 (3), 270–280. https://doi.org/10.1016/j.hlc.2014.09.012
  19. Black-Maier, E., Ren, X., & Steinberg, B. et al. (2018). Catheter ablation of atrial fibrillation in patients with heart failure and preserved ejection fraction. Heart rhythm, 15 (5), 651–657. https://doi.org/10.1016/j.hrthm.2017.12.001
  20. Briceño, D. F., Markman, T. M., & Lupercio, F. et al. (2018). Catheter ablation versus conventional treatment of atrial fibrillation in patients with heart failure with reduced ejection fraction: a systematic review and meta-analysis of randomized controlled trials. Journal of interventional cardiac electrophysiology: an international journal of arrhythmias and pacing, 53 (1), 19–29. https://doi.org/10.1007/s10840-018-0425-0
  21. Zhu, M., Zhou, X., & Cai, H. et al. (2016). Catheter ablation versus medical rate control for persistent atrial fibrillation in patients with heart failure: A PRISMA-compliant systematic review and meta-analysis of randomized controlled trials. Medicine. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5265865/. https://doi.org/10.1097/MD.0000000000004377
  22. Chen, C. C., Zhou, X., & Zhu, M. et al. (2018). Catheter ablation versus medical therapy for patients with persistent atrial fibrillation: a systematic review and meta-analysis of evidence from randomized controlled trials. Journal of interventional cardiac electrophysiology: an international journal of arrhythmias and pacing, 52 (1), 9–18. https://doi.org/10.1007/s10840-018-0349-8
  23. Zhang, B., Shen, D., & Feng, S. et al. (2016). Efficacy and safety of catheter ablation vs. rate control of atrial fibrillation in systolic left ventricular dysfunction: A meta-analysis and systematic review. Herz, 41 (4), 342–350. https://doi.org/10.1007/s00059-015-4372-6
  24. Santos, S. N., Henz, B. D., & Zanatta, A. R. et al. (2014). Impact of atrial fibrillation ablation on left ventricular filling pressure and left atrial remodeling. Arquivos brasileiros de cardiologia, 103 (6), 485–492. https://doi.org/10.5935/abc.20140152
  25. Luong, C., Barnes, M. E., & Tsang, T. S. (2014). Atrial fibrillation and heart failure: cause or effect? Current heart failure reports, 11 (4), 463–470. https://doi.org/10.1007/s11897-014-0229-1
  26. Smer, A., Salih, M., & Darrat, Y. H. et al. (2018). Meta-analysis of randomized controlled trials on atrial fibrillation ablation in patients with heart failure with reduced ejection fraction. Clinical cardiology, 41 (11), 1430–1438. https://doi.org/10.1002/clc.23068
  27. Barmano, N., Charitakis, E., & Karlsson, J. et al. (2019). Predictors of improvement in arrhythmia specific symptoms and health related quality of life after catheter ablation of atrial fibrillation. Clinical cardiolog, 42 (2), 247–255. https://doi.org/10.1002/clc.23134
  28. Scanavacca, M, & Alcides Bocchi, E. (2018). Catheter Ablation for Atrial Fibrillation in Patients with Heart Failure. Arquivos brasileiros de cardiologia, 110 (4), 300–302.
  29. Wang, T. J., Larson, M. G., & Levy, D. et al. (2003). Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation, 107 (23), 2920–2925. https://doi.org/10.1161/01.CIR.0000072767.89944.6E
  30. Khan, S. U., Rahman, H., Talluri, S., & Kaluski, E. (2018). The Clinical Benefits and Mortality Reduction Associated With Catheter Ablation in Subjects With Atrial Fibrillation: A Systematic Review and Meta-Analysis. JACC. Clinical electrophysiology, 4 (5), 626–635. https://doi.org/10.1016/j.jacep.2018.03.003
Короткая ссылка на эту статью: http://promedosvity.in.ua/?p=3722

Оставить комментарий

You must be logged in to post a comment.